Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown significant growth, indicating a positive trend in the healthcare sector [1]. Group 1: Index Performance - The CSI Healthcare Equipment and Services Index increased by 1.49%, reaching 15,129.06 points, with a trading volume of 32.457 billion [1]. - Over the past month, the index has risen by 9.35%, by 9.86% over the last three months, and by 8.89% year-to-date [1]. Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these companies [1]. - The top ten weighted companies in the index include Mindray Medical (9.08%), United Imaging (7.41%), Aier Eye Hospital (7.13%), and others [1]. - The index's holdings are primarily from the Shenzhen Stock Exchange (59.69%) and the Shanghai Stock Exchange (40.31%) [1]. Group 3: Industry Representation - The index exclusively represents the pharmaceutical and healthcare industry, with a 100% allocation to this sector [1]. Group 4: Index Adjustment and Fund Tracking - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2]. - Public funds tracking the healthcare index include various Southern and Tianhong funds, as well as ETFs from multiple asset management companies [2].

Core Viewpoint - Southbound funds recorded a net purchase of HKD 35.88 billion, setting a new historical record for single-day net inflows [1] Group 1: Market Performance - The CSI Hong Kong Stock Connect Healthcare Index increased by 7.3% this week [1] - The CSI Hong Kong Stock Connect Internet Index rose by 3.5% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index gained 3.4% [1] - The CSI Hong Kong Stock Connect Consumer Theme Index saw a 1.9% increase [1] - The Hang Seng Technology Index experienced a 1.5% rise [1] Group 2: Fund Inflows - The Hang Seng Technology ETF (513010) attracted over HKD 1.5 billion in net inflows over the past month [1]

Core Viewpoint - The Shanghai Composite Index opened high but closed lower, with the CSI 300 High Beta Index declining by 0.76% to 2613.17 points, with a trading volume of 240.68 billion yuan [1] Group 1: Index Performance - The CSI 300 High Beta Index has increased by 7.95% over the past month, 15.34% over the past three months, and 9.60% year-to-date [2] - The index is based on a sample space of its parent index, ranking securities by their beta values over the past year [2] Group 2: Index Holdings - The top ten weights in the CSI 300 High Beta Index are: Guotai Junan (13.31%), Xinyi Sheng (2.39%), Zhongji Xuchuang (2.18%), Tonghuashun (1.56%), Tianfu Communication (1.47%), China Shipbuilding Industry (1.33%), China State Shipbuilding (1.30%), Zhifei Biological (1.28%), Tianqi Lithium (1.27%), and Cambrian (1.22%) [2] - The market share of the CSI 300 High Beta Index holdings is 57.15% from the Shanghai Stock Exchange and 42.85% from the Shenzhen Stock Exchange [2] Group 3: Industry Composition - The industry composition of the CSI 300 High Beta Index includes: Industrial (25.63%), Financial (25.47%), Information Technology (17.02%), Healthcare (10.66%), Communication Services (9.87%), Materials (4.36%), Consumer Discretionary (4.14%), and Consumer Staples (2.84%) [3] - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December [3]

Group 1 - The core viewpoint of the news highlights the positive performance of various healthcare indices, with the Hang Seng Hong Kong Stock Connect Innovative Drug Index rising by 1.0% and the overall healthcare sector indices showing upward trends [1][2][3] - The Hang Seng Innovative Drug ETF (159316) has seen a net inflow of funds for five consecutive trading days, reaching a record size of over 1.2 billion yuan [1][2] - The indices mentioned focus on leading companies in the pharmaceutical and biotechnology sectors, with specific indices tracking innovative drug companies in both Hong Kong and A-shares [2][3] Group 2 - The rolling price-to-earnings (P/E) ratio for the Hang Seng Hong Kong Stock Connect Innovative Drug Index is reported at 57.4 times, while the P/E ratio for the Hong Kong Stock Connect Medical and Health Comprehensive Index stands at 31.6 times [2][3] - The A-share Innovative Drug Industry Index has a rolling P/E ratio of 52.6 times, indicating a strong valuation in the innovative drug sector [2] - The rolling P/E ratio for the Biotech Theme Index is noted at 54.9 times, reflecting the valuation dynamics within the biotech industry [2]

Core Points - The China Securities Index Hong Kong Stock Connect Technology Index (CSI Hong Kong Technology, 931573) experienced a decline of 0.61%, closing at 3373.85 points with a trading volume of 76.047 billion yuan on August 12 [1] - Over the past month, the CSI Hong Kong Technology Index has increased by 7.35%, by 11.64% over the last three months, and by 41.30% year-to-date [1] - The index comprises 50 large-cap technology companies with high R&D investment and revenue growth, reflecting the overall performance of technology leaders within the Hong Kong Stock Connect [1] Market Composition - The CSI Hong Kong Technology Index is fully composed of stocks listed on the Hong Kong Stock Exchange, with a 100% allocation [1] - The sector distribution of the index includes: Consumer Discretionary at 37.12%, Information Technology at 26.79%, Communication Services at 17.89%, Healthcare at 17.18%, and Industrials at 1.03% [1] Index Adjustment Mechanism - The sample of the CSI Hong Kong Technology Index is adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2] - New securities entering the Hong Kong Stock Connect that rank in the top ten by market capitalization will be added to the index on the eleventh trading day after their listing [2]

Group 1 - The Shanghai Stock Exchange National New Sci-Tech Board State-Owned Enterprises Index (950253) opened lower and fluctuated, down 0.7% to 1080.78 points, with a trading volume of 26.665 billion yuan [1] - Over the past month, the index has increased by 8.98%, by 9.11% over the past three months, and by 11.89% year-to-date [1] - The index is composed of state-owned enterprises listed on the Sci-Tech Board or companies with state capital participation without actual control, reflecting the overall performance of state-owned enterprises in the Sci-Tech Board [1] Group 2 - The index samples are adjusted every six months, with adjustments implemented on the next trading day after the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with temporary adjustments made under special circumstances [2] - Companies that are delisted or undergo mergers, acquisitions, or splits are processed according to calculation and maintenance guidelines [2]

Core Insights - The CSI Hong Kong-Shenzhen Technology 100 Index (SHS Technology 100) has shown a significant upward trend, with a 7.29% increase over the past month, 9.06% over the past three months, and a year-to-date increase of 27.81% [1] Group 1: Index Performance - The SHS Technology 100 Index opened lower but closed higher, reaching 11,262.4 points with a trading volume of 96.186 billion [1] - The index is composed of 100 leading technology companies selected from the mainland and Hong Kong markets, reflecting the overall performance of representative technology stocks [1] Group 2: Index Composition - The top ten holdings of the SHS Technology 100 Index include Tencent Holdings (10.46%), Xiaomi Group-W (9.51%), Alibaba-W (9.48%), Meituan-W (7.78%), BYD (4.96%), and others [1] - The market distribution of the index holdings shows that the Hong Kong Stock Exchange accounts for 63.13%, Shenzhen Stock Exchange for 19.44%, and Shanghai Stock Exchange for 17.42% [1] Group 3: Sector Allocation - The sector allocation of the index holdings includes Consumer Discretionary (29.50%), Information Technology (25.83%), Communication Services (19.29%), Healthcare (16.01%), Industrials (8.87%), and Materials (0.51%) [2] Group 4: Index Adjustment Mechanism - The index samples are adjusted semi-annually, typically on the next trading day after the second Friday of June and December, with a sample adjustment ratio not exceeding 40% [2] - Special adjustments may occur under certain circumstances, such as delisting or significant corporate actions [2] Group 5: Tracking Funds - Public funds tracking the SHS Technology 100 include Huaan CSI Hong Kong-Shenzhen Technology 100 ETF and Morgan CSI Hong Kong-Shenzhen Technology 100 ETF [3]

Group 1 - The majority of broad-based index PE valuations are currently above the historical percentile of 50%, while the ChiNext index PE valuation is around the 15th percentile, indicating relatively low valuations and a continuous rise in market trading sentiment [1] - The Science and Technology Innovation and Entrepreneurship ETF (588360) tracks the Science and Technology Innovation and Entrepreneurship 50 Index (931643), which can have a daily fluctuation of up to 20%. This index selects 50 large-cap, liquid technology innovation companies from the Science and Technology Board and the ChiNext to reflect the overall performance of representative innovative enterprises in these two sectors [1] - The index components cover multiple high-tech fields, including information technology and healthcare, with a focus on growth-style allocation [1] Group 2 - Investors without stock accounts can consider the Guotai CSI Science and Technology Innovation and Entrepreneurship 50 ETF Initiated Linkage C (013307) and Guotai CSI Science and Technology Innovation and Entrepreneurship 50 ETF Initiated Linkage A (013306) [1]

金融界8月5日消息，上证指数高开高走，中证香港美国上市中美科技指数 (港美上市中美科技，931734) 报5691.57点。 数据统计显示，中证香港美国上市中美科技指数近一个月上涨5.81%，近三个月上涨18.50%，年至今上 涨26.68%。 据了解，中证香港美国上市中美科技指数从中国香港和美国上市的证券中选取流动性较好、市值较高的 中国和美国科技行业公司证券作为指数样本，采用等权重加权计算，以反映中国香港和美国上市的中美 两国科技行业公司的整体表现。该指数以2010年12月31日为基日，以1000.0点为基点。 从指数持仓来看，中证香港美国上市中美科技指数十大权重分别为：康方生物（3.18%）、Advanced Micro Devices Inc.（2.65%）、Oracle Corp（2.6%）、华虹半导体（2.41%）、蔚来（2.33%）、NVIDIA Corp（2.3%）、信达生物（2.28%）、快手-W（2.25%）、Avago Technologies Ltd（2.22%）、中芯国际 （2.22%）。 从中证香港美国上市中美科技指数持仓的市场板块来看，纳斯达克全球精选市场证券交易所 (Conso ...

Group 1 - The Hang Seng New Economy Index tracks the largest 50 stocks in the "new economy" sector within the Hong Kong Stock Connect, primarily including information technology, consumer discretionary, and healthcare [2] - The index experienced a daily change of 1.2% and has a rolling price-to-earnings (P/E) ratio of 23.3 times [2] - The Hang Seng Technology ETF follows the Hang Seng Technology Index, which consists of the 30 largest stocks related to technology, with over 90% of the index comprising information technology and consumer discretionary sectors [2] Group 2 - The Hong Kong Stock Connect Pharmaceutical ETF tracks the CSI Hong Kong Stock Connect Pharmaceutical and Healthcare Composite Index, which includes 50 liquid and large-cap stocks in the healthcare sector, accounting for over 90% of the index [2] - The index had a daily change of 2% and a rolling P/E ratio of 21.2 times [2] - The Hong Kong Stock Connect Internet ETF follows the CSI Hong Kong Stock Connect Internet Index, consisting of 30 leading internet companies, primarily in information technology and consumer discretionary [3] Group 3 - The Hong Kong Stock Connect Consumer ETF tracks the CSI Hong Kong Stock Connect Consumer Theme Index, which includes 50 liquid and large-cap consumer stocks, with nearly 60% in consumer discretionary [3] - The index experienced a daily change of 1.2% and has a rolling P/E ratio of 20.7 times [3] - The data for the indices is sourced from Mind, with the closing data as of August 4, 2025, and rolling P/E ratios as of August 1, 2025 [2][3]